CDRH holds a virtual town hall on chemical characterization testing for biocompatibility on September 23, from 1 to 2 p.m. Eastern. The subject is extraction methodology under ISO 10993-18 and the implementation problems FDA keeps seeing in submissions. Registration is not required and the session runs on Microsoft Teams.
The window for written questions closed August 26 at CDRH.Biocomp@fda.hhs.gov, and FDA will not take questions live. Slides go to CDRH Learn under Biocompatibility afterward.
FDA recognized ISO 10993-1:2025 only in part earlier this month and left clause 6.9 out. If your device needs chemical characterization, settle the extraction conditions before you pay a lab to run the study, because that choice is what the rest of the package rests on.